RDHL - RedHill Biopharma - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

108.7M

Cash

19.98M

Avg Qtr Burn

-7.296M

Short % of Float

0.00%

Insider Ownership

4.38%

Institutional Own.

11.27%

Qtr Updated

12/31/22

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Movantik® (naloxegol) Details Opioid-induced constipation (OIC)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Aemcolo® (rifamycin) Details Diarrhea caused by non-invasive strains of Escherichia coli (E.coli)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Talicia® (omeprazole magnesium, amoxicillin and rifabutin) Details Helicobacter pylori (H. pylori)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-104 Details Crohn's disease	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Opaganib (ABC294640, Yeliva®) Details COVID-19	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-204 Details Bacterial infection	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-102 (Bekinda®) Details Intestinal infection, Digestive tract, Stomach	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-107 (upamostat) Details COVID-19	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-106 Details Bowel preparation , Breast cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RHB-102 (Bekinda®) Details Irritable bowel syndrome, Bowel disorder, Psychiatric disorder, Post-traumatic stress disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.